Considering the patient's current medications, which of the following is the most likely effect on the progression of their major depressive disorder if their medication regimen is not adjusted?
Potential worsening of depressive symptoms due to serotonin syndrome risk from concurrent use of FLUoxetine and Sertraline. Stable depressive symptoms as the current medications are at optimal therapeutic doses. Potential improvement in depressive symptoms due to the analgesic effect of Acetaminophen/Hydrocodone on comorbid pain. Improvement in depressive symptoms due to the synergistic effect of FLUoxetine and Sertraline.